Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

On Tuesday 17th April 2018, the Department of Physiology Anatomy and Genetics (DPAG) officially opened its new Centre for Integrative Neuroscience, and Sir Colin Blakemore was here to pull the curtain on the commemorative plaque. 

The event was celebrated with a drinks and canapes reception in the Sherrington foyer, and marked by the inaugural Sir Charles Sherrington Lecture.

The Centre for Integrative Neuroscience has been established as part of the Department's ongoing re-organisation and is to be located in the east wing of the Sherrington Building, extending into the adjacent Henry Wellcome Building.

The focus of this centre will be a multidisciplinary study of mammalian neural circuits, which will bring together DPAG's world leading expertise in the investigation of how the cells of the nervous system are formed, migrate into position, and assemble into specific circuits, how those cells communicate with each other and encode information, and how the circuits they form give rise to behaviour.

Blakemore, now an Emeritus Professor of DPAG, was formerly Head of Department and Waynflete Professor of Physiology. His contribution to neuroscience is the part he played in establishing the concept of neural plasticity, the capacity of the brain to reorganise itself as a result of the pattern of activity passing through its connections, the subject of the Sir Charles Sherrington Lecture this year.

To view more pictures from the event, click here.

In case you weren't able to make the event, you can watch some highlights below.

Similar stories

New European initiative to accelerate the discovery and validation of biomarkers for neurodegenerative diseases

Members of the European Platform for Neurodegenerative Diseases (EPND) will establish a collaborative platform for efficient sample and data sharing, linking existing European research infrastructures to accelerate the discovery of biomarkers, new diagnostics and treatments for the benefit of people with neurodegenerative diseases such as Alzheimer's and Parkinson's.

Experimental Medicine and Industry Partnership

The recent launch event of the Experimental Medicine Industry Partnership was an exciting collaboration between industry representatives and researchers from the University of Oxford. During the event, a series of workshops were held to discuss opportunities, challenges, and future directions for the application of experimental medicine in psychiatric drug development.

Major research network to investigate body clock and stroke

The University of Oxford is part of a new international research network to investigate the interactions between the biology of the body's internal clock and the disordered physiological processes associated with stroke.

Mapping uncharted networks in the progression of Parkinson’s

A major new $9 million project funded by the Aligning Science Across Parkinson’s (ASAP) initiative will map the original circuits vulnerable to Parkinson’s on an unprecedented scale. The project is a collaboration between a core team of Stephanie Cragg, Richard Wade-Martins, and Peter Magill at Oxford, Mark Howe at Boston University and Dinos Meletis at the Karolinska Institute, as well as collaborators Yulong Li at Peking University and Michael Lin at Stanford University.